Elena Fragapane

779 total citations
23 papers, 615 citations indexed

About

Elena Fragapane is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Elena Fragapane has authored 23 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 8 papers in Infectious Diseases and 5 papers in Immunology. Recurrent topics in Elena Fragapane's work include Influenza Virus Research Studies (15 papers), Respiratory viral infections research (9 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Elena Fragapane is often cited by papers focused on Influenza Virus Research Studies (15 papers), Respiratory viral infections research (9 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Elena Fragapane collaborates with scholars based in Italy, Germany and United States. Elena Fragapane's co-authors include Audino Podda, Giuseppe Del Giudice, Roberto Gasparini, Emanuele Montomoli, Rino Rappuoli, Teresa Pozzi, M Minutello, Angelika Banzhoff, Nicola Groth and Michele Pellegrini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and European Journal of Immunology.

In The Last Decade

Elena Fragapane

23 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena Fragapane Italy 13 437 291 143 101 49 23 615
Edith C. Sannella United States 10 470 1.1× 171 0.6× 215 1.5× 57 0.6× 38 0.8× 13 603
Steve Rockman Australia 14 441 1.0× 293 1.0× 240 1.7× 130 1.3× 43 0.9× 26 777
Sarah A. Frech United States 9 253 0.6× 371 1.3× 195 1.4× 123 1.2× 16 0.3× 10 815
Diane O’Brien United States 7 642 1.5× 267 0.9× 205 1.4× 102 1.0× 88 1.8× 10 765
Pascale Van Belle Belgium 7 274 0.6× 190 0.7× 109 0.8× 108 1.1× 14 0.3× 7 463
Cecilia Chui United Kingdom 5 584 1.3× 535 1.8× 246 1.7× 136 1.3× 48 1.0× 6 925
Luisanna Zedda Italy 8 266 0.6× 298 1.0× 115 0.8× 77 0.8× 20 0.4× 8 485
Fien De Boever Belgium 10 361 0.8× 185 0.6× 179 1.3× 74 0.7× 22 0.4× 17 491
Cathy Maes Belgium 10 326 0.7× 128 0.4× 108 0.8× 45 0.4× 22 0.4× 13 441
Françoise Weber France 15 537 1.2× 380 1.3× 128 0.9× 131 1.3× 11 0.2× 17 867

Countries citing papers authored by Elena Fragapane

Since Specialization
Citations

This map shows the geographic impact of Elena Fragapane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Fragapane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Fragapane more than expected).

Fields of papers citing papers by Elena Fragapane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Fragapane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Fragapane. The network helps show where Elena Fragapane may publish in the future.

Co-authorship network of co-authors of Elena Fragapane

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Fragapane. A scholar is included among the top collaborators of Elena Fragapane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Fragapane. Elena Fragapane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bekkat-Berkani, Rafik, et al.. (2022). Public health perspective of a pentavalent meningococcal vaccine combining antigens of MenACWY-CRM and 4CMenB. Journal of Infection. 85(5). 481–491. 12 indexed citations
2.
Moriconi, Alessio, Simone Bufali, Simona Cianetti, et al.. (2020). A new strategy for preparing a tailored meningococcal ACWY conjugate vaccine for clinical testing. Vaccine. 38(23). 3930–3933. 3 indexed citations
3.
4.
Izu, Allen, et al.. (2015). Five year follow-up after primary vaccination against tick-borne encephalitis in children. Vaccine. 33(15). 1824–1829. 12 indexed citations
5.
Herbinger, Karl–Heinz, Frank von Sonnenburg, Hans Dieter Nothdurft, et al.. (2013). A phase II study of an investigational tetravalent influenza vaccine formulation combining MF59®. Human Vaccines & Immunotherapeutics. 10(1). 92–99. 6 indexed citations
6.
Bardelli, Monia, Francesca Buricchi, Simona Tavarini, et al.. (2013). Ex Vivo Analysis of Human Memory B Lymphocytes Specific for A and B Influenza Hemagglutinin by Polychromatic Flow-Cytometry. PLoS ONE. 8(8). e70620–e70620. 9 indexed citations
7.
Spensieri, Fabiana, Erica Borgogni, Luisanna Zedda, et al.. (2013). Human circulating influenza-CD4 + ICOS1 + IL-21 + T cells expand after vaccination, exert helper function, and predict antibody responses. Proceedings of the National Academy of Sciences. 110(35). 14330–14335. 80 indexed citations
8.
9.
Tregnaghi, Miguel, Daniel Stamboulián, Elena Fragapane, et al.. (2012). Immunogenicity, safety, and tolerability of two trivalent subunit inactivated influenza vaccines: a phase III, observer-blind, randomized, controlled multicenter study.. PubMed. 25(3). 216–25. 5 indexed citations
10.
Buricchi, Francesca, Monia Bardelli, Carmine Malzone, et al.. (2012). Impact of preexisting memory to seasonal A/H1N1 influenza virus on the immune response following vaccination against avian A/H5N1 virus. European Journal of Immunology. 43(3). 641–648. 13 indexed citations
11.
Giudice, Giuseppe Del, Elena Fragapane, Giovanni Della Cioppa, & Rino Rappuoli. (2012). Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza. Expert Opinion on Biological Therapy. 13(1). 121–135. 10 indexed citations
12.
Czajka, Hanna, Serhat Ünal, Sercan Ulusoy, et al.. (2012). A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects.. PubMed. 53(3). 136–42. 20 indexed citations
13.
14.
Fragapane, Elena, et al.. (2010). A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly. Clinical and Vaccine Immunology. 17(11). 1817–1819. 32 indexed citations
15.
Banzhoff, Angelika, Michele Pellegrini, Giuseppe Del Giudice, et al.. (2008). MF59®‐adjuvanted vaccines for seasonal and pandemic influenza prophylaxis. Influenza and Other Respiratory Viruses. 2(6). 243–249. 59 indexed citations
16.
Durando, Paolo, Daniela Fenoglio, Antonio Boschini, et al.. (2007). Safety and Immunogenicity of Two Influenza Virus Subunit Vaccines, with or without MF59 Adjuvant, Administered to Human Immunodeficiency Virus Type 1-Seropositive and -Seronegative Adults. Clinical and Vaccine Immunology. 15(2). 253–259. 59 indexed citations
17.
Baldo, Vincenzo, et al.. (2007). Response of Influenza Vaccines Against Heterovariant Influenza Virus Strains in Adults with Chronic Diseases. Journal of Clinical Immunology. 27(5). 542–547. 38 indexed citations
18.
Giudice, Giuseppe Del, Elena Fragapane, Roberto Bugarini, et al.. (2006). Vaccines with the MF59 Adjuvant Do Not Stimulate Antibody Responses against Squalene. Clinical and Vaccine Immunology. 13(9). 1010–1013. 68 indexed citations
19.
Gasparini, Roberto, Teresa Pozzi, Emanuele Montomoli, et al.. (2001). Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects. European Journal of Epidemiology. 17(2). 135–140. 105 indexed citations
20.
Gasparini, Roberto, et al.. (1997). Immunity to diphtheria in Siena. Epidemiology and Infection. 119(2). 203–208. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edith C. Sannella Breakdown of academic impact, for papers by Steve Rockman Breakdown of academic impact, for papers by Sarah A. Frech Breakdown of academic impact, for papers by Diane O’Brien Breakdown of academic impact, for papers by Pascale Van Belle Breakdown of academic impact, for papers by Cecilia Chui Breakdown of academic impact, for papers by Luisanna Zedda Breakdown of academic impact, for papers by Fien De Boever Breakdown of academic impact, for papers by Cathy Maes Breakdown of academic impact, for papers by Françoise Weber
Rankless by CCL
2026